Page last updated: 2024-10-27

fluoxetine and Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency

fluoxetine has been researched along with Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Capuozzo, A1
Montefusco, S1
Cacace, V1
Sofia, M1
Esposito, A1
Napolitano, G1
Nusco, E1
Polishchuk, E1
Pizzo, MT1
De Risi, M1
De Leonibus, E1
Sorrentino, NC1
Medina, DL1

Other Studies

1 other study available for fluoxetine and Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Deficiency

ArticleYear
Fluoxetine ameliorates mucopolysaccharidosis type IIIA.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2022, 04-06, Volume: 30, Issue:4

    Topics: Animals; Disease Models, Animal; Fibroblasts; Fluoxetine; Heparitin Sulfate; Hydrolases; Mice; Mucop

2022